English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04959981 /

ERAS-007-02

Phase 1b/2, Open-Label, Multicenter Study Of ERAS-007 In Combination With Other Anti-Cancer Therapies In Patients With Advanced Non-Small-Cell Lung Cancer (HERKULES-2)

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: